| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds issue common stock employee stock purchase plan | 272 | 141 |
| Net cash flows provided by financing activities | 59,027 | 31,897 |
| Net increase in cash | 24,974 | 8,765 |
| Cash and cash equivalents at beginning of period | 22,358 | - |
| Cash and cash equivalents at end of period | 47,332 | - |
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. (LUCD)